Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension
Completed
Novartis Pharmaceuticals
Phase 4
2004-12-01
This trial is designed to study the efficacy of an amlodipine besylate/benazepril treatment
regimen versus an amlodipine treatment regimen in the treatment of severe hypertension.
Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions
Completed
Dr. Reddy's Laboratories Limited
Phase 1
2004-03-01
The objective of this study was to compare the single-dose relative bioavailability of Dr.
Reddy's Laboratories, Ltd. and Lotrel®) 10 mg amlodipine besylate/20 mg benazepril
hydrochloride capsules, under fasting conditions.
Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions
Completed
Dr. Reddy's Laboratories Limited
Phase 1
2005-04-01
The objective of this study was to compare the single-dose relative bioavailability of Dr.
Reddy's Laboratories, Ltd. and Lotrel®) 10 mg amlodipine besylate/20 mg benazepril
hydrochloride capsules, under non-fasting (fed) conditions.
Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions
Completed
Dr. Reddy's Laboratories Limited
Phase 1
2007-03-01
The purpose of this study single dose bioequivalence of Amlodipine Besylate/Benazepril HCl 10
mg/40 mg capsules with Lotrel® capsules in healthy human subjects and monitor clinical
status, adverse events and laboratory investigations and assess relative safety and tolerance
under fed conditions.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.